Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the maintain iron trial)

HIGHLIGHTS

• who: Suthiya Anumas from the Thammasat University have published the research work: Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial), in the Journal: Scientific Reports Scientific Reports of 13/06/2022
• what: In the initial study protocol, the authors aimed to test whether 100-mg IV iron was not inferior to 200-mg.
• how: Quality of life measured by the EQ-5D questionnaire was evaluated every six months. The authors presented time to withholding IV iron and time to iron rescue . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.